Greg Dueck

846 total citations
13 papers, 570 citations indexed

About

Greg Dueck is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Greg Dueck has authored 13 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Greg Dueck's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Greg Dueck is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Greg Dueck collaborates with scholars based in Canada, United States and United Kingdom. Greg Dueck's co-authors include Neil Chua, Laurie H. Sehn, Marek Trněný, John G. Gribben, Pieternella J. Lugtenburg, Gilles Salles, Bruce D. Cheson, Kamal Bouabdallah, Oliver W. Press and Günter Fingerle‐Rowson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Greg Dueck

13 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Dueck Canada 9 475 344 229 168 90 13 570
Kamal Bouabdallah France 11 439 0.9× 350 1.0× 237 1.0× 100 0.6× 33 0.4× 27 531
Iván Dlouhy Spain 12 437 0.9× 311 0.9× 130 0.6× 150 0.9× 97 1.1× 26 557
Abdulwahab J. Al-Tourah Canada 9 525 1.1× 364 1.1× 189 0.8× 150 0.9× 25 0.3× 18 616
B Coiffier France 7 392 0.8× 233 0.7× 267 1.2× 168 1.0× 55 0.6× 13 519
J Pierson United States 12 519 1.1× 340 1.0× 242 1.1× 141 0.8× 61 0.7× 13 651
Finlay MacDougall United Kingdom 7 374 0.8× 352 1.0× 166 0.7× 302 1.8× 26 0.3× 13 680
Gottfried von Keudell United States 13 293 0.6× 243 0.7× 151 0.7× 104 0.6× 30 0.3× 46 560
Baha Alkuzweny United States 5 369 0.8× 255 0.7× 184 0.8× 95 0.6× 23 0.3× 7 459
Maria Delioukina United States 13 426 0.9× 308 0.9× 168 0.7× 168 1.0× 172 1.9× 33 652
Vera Vanhentenrijk Belgium 12 374 0.8× 241 0.7× 219 1.0× 143 0.9× 30 0.3× 13 571

Countries citing papers authored by Greg Dueck

Since Specialization
Citations

This map shows the geographic impact of Greg Dueck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Dueck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Dueck more than expected).

Fields of papers citing papers by Greg Dueck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Dueck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Dueck. The network helps show where Greg Dueck may publish in the future.

Co-authorship network of co-authors of Greg Dueck

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Dueck. A scholar is included among the top collaborators of Greg Dueck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Dueck. Greg Dueck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gerrie, Alina S., Sean Young, Tracy Tucker, et al.. (2021). Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada. Leukemia Research. 103. 106538–106538. 2 indexed citations
2.
Gerrie, Alina S., Sean Young, Tracy Tucker, et al.. (2020). Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada. Leukemia Research. 91. 106335–106335. 12 indexed citations
3.
4.
Cheson, Bruce D., Neil Chua, Jiřı́ Mayer, et al.. (2018). Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study. Journal of Clinical Oncology. 36(22). 2259–2266. 100 indexed citations
5.
6.
7.
Sehn, Laurie H., Neil Chua, Jiří Mayer, et al.. (2015). GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.. Journal of Clinical Oncology. 33(15_suppl). LBA8502–LBA8502. 4 indexed citations
8.
Sehn, Laurie H., Neil Chua, Jiřı́ Mayer, et al.. (2015). GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.. Journal of Clinical Oncology. 33(18_suppl). LBA8502–LBA8502. 15 indexed citations
9.
Dueck, Greg, Neil Chua, Daygen L. Finch, et al.. (2014). Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma. Cancer. 121(5). 716–723. 76 indexed citations
10.
Dueck, Greg, Neil Chua, Daygen L. Finch, et al.. (2013). Final Report Of a Phase II Clinical Trial Of Lenalidomide Monotherapy For T-Cell Lymphoma. Blood. 122(21). 4376–4376. 2 indexed citations
11.
Evans, Robert P., Greg Dueck, Sunita Ghosh, et al.. (2011). Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma. Leukemia Research. 35(12). 1637–1643. 14 indexed citations
12.
Dueck, Greg, Neil Chua, Daygen L. Finch, et al.. (2010). Interim report of a phase 2 clinical trial of lenalidomide for T‐cell non‐Hodgkin lymphoma. Cancer. 116(19). 4541–4548. 76 indexed citations
13.
Dueck, Greg, Neil Chua, Darrell White, et al.. (2009). Activity of lenalidomide in a phase II trial for T-cell lymphoma: Report on the first 24 cases. Journal of Clinical Oncology. 27(15_suppl). 8524–8524. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamal Bouabdallah Breakdown of academic impact, for papers by Iván Dlouhy Breakdown of academic impact, for papers by Abdulwahab J. Al-Tourah Breakdown of academic impact, for papers by B Coiffier Breakdown of academic impact, for papers by J Pierson Breakdown of academic impact, for papers by Finlay MacDougall Breakdown of academic impact, for papers by Gottfried von Keudell Breakdown of academic impact, for papers by Baha Alkuzweny Breakdown of academic impact, for papers by Maria Delioukina Breakdown of academic impact, for papers by Vera Vanhentenrijk
Rankless by CCL
2026